I served as the White House’s top biosecurity official. Here’s what I’m watching for with AI

AI SUMMARY

# Investment Summary The article argues that AI biosecurity risks require regulatory frameworks with defined action triggers rather than relying on voluntary industry compliance, potentially signaling increased regulatory scrutiny and compliance costs for AI companies like OpenAI, Google, and Meta as governments establish mandatory safety standards. This regulatory shift could impact valuations of AI developers while creating opportunities for biosecurity and AI safety-focused companies that develop monitoring and compliance solutions.